Pharmicell Co., Ltd. (KRX: 005690)

Pharmicell Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Oct 10, 2024	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
Market Capitalization	307,221	164,023	213,530	370,682	173,375	75,442
Market Cap Growth	-5.97%	-23.19%	-42.40%	113.80%	129.81%	169.18%
Enterprise Value	159,109	172,343	219,632	376,638	176,424	72,037
Last Close Price	5120.00	3780.00	5100.00	10522.25	7190.99	3732.33
PE Ratio	-	-6.22	-10.92	-15.14	-1.26	-14.49
PS Ratio	9.33	4.91	19.22	36.05	24.02	10.49
PB Ratio	2.74	1.99	2.10	4.48	17.50	5.47
P/FCF Ratio	-20.13	-51.80	-14.88	-22.02	-19.38	-12.87
P/OCF Ratio	-20.86	-61.03	-17.99	-22.93	-20.60	-14.67
EV/Sales Ratio	6.64	5.16	19.77	36.63	24.44	10.02
EV/EBITDA Ratio	-25.73	-40.56	-19.26	-26.66	-17.56	-32.10
EV/EBIT Ratio	-17.13	-21.96	-15.41	-24.49	-16.84	-28.97
EV/FCF Ratio	-20.35	-54.42	-15.31	-22.38	-19.72	-12.29
Debt / Equity Ratio	0.14	0.11	0.27	0.18	1.40	0.63
Debt / FCF Ratio	-1.50	-2.79	-1.89	-0.90	-1.55	-1.49
Asset Turnover	0.21	0.28	0.09	0.16	0.27	0.36
Inventory Turnover	5.05	5.13	2.65	5.22	4.84	4.81
Quick Ratio	1.05	0.68	0.89	0.73	0.70	4.77
Current Ratio	1.34	1.08	1.07	0.91	0.85	5.41
Return on Equity (ROE)	-29.25%	-27.94%	-19.14%	-39.23%	-100.35%	-39.62%
Return on Assets (ROA)	-4.98%	-4.16%	-7.50%	-14.69%	-24.61%	-7.89%
Return on Capital (ROIC)	-5.33%	-4.46%	-7.85%	-15.78%	-28.28%	-8.58%
Earnings Yield	-11.99%	-15.67%	-8.26%	-4.90%	-6.84%	-5.24%
FCF Yield	-2.55%	-1.93%	-6.72%	-4.54%	-5.16%	-7.77%
Buyback Yield / Dilution	-7.56%	-11.91%	-44.48%	-1161.85%	86.50%	8.16%
Total Shareholder Return	-7.56%	-11.91%	-44.48%	-1161.85%	86.50%	8.16%

Source: S&P Capital IQ. Standard template. Financial Sources.